Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN

2017101 citationsJournal Articlebronze Open Access

Authors

John-Paul Kilday · Medical University of Vienna

Massimo Caldarelli · University of Liverpool

Luca Massimi · University Medical Center Hamburg-Eppendorf

Robert Hsin-Hung Chen · Medical University of Vienna

Yi Yen Lee · Medical University of Vienna

Muh‐Lii Liang · Universität Hamburg

Jeannette Parkes

Abstract

Intracystic interferon-alpha can delay disease progression and potentially offer a protracted time to definitive surgery or radiotherapy in pediatric cystic craniopharyngioma, yet demonstrates a favorable toxicity profile compared with other therapeutic modalities-important factors for this developing age group. A prospective, randomized international clinical trial assessment is warranted.

Topics & Keywords

Pituitary Gland Disorders and Treatments Growth Hormone and Insulin-like Growth Factors Glioma Diagnosis and Treatment

Publication Details

Published in: Neuro-Oncology

Volume 19, Issue 10, pp. 1398-1407

DOI: 10.1093/neuonc/nox056

Field-Weighted Citation Impact: 6.03

Command Palette

Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN

Authors

Abstract

Topics & Keywords

Publication Details